Methoxypoly(ethylene glycol)
| Mn | Product ID |
| 10,000 | 06020100109 |
| 12,000 | 06020100110 |
| 20,000 | 06020100112 |
| 21,500 | 06020100148 |
| 22,000 | 06020100161 |
| 23,000 | 06020100199 |
| 30,000 | 06020100113 |
| 40,000 | 06020100115 |
| 50,000 | 06020100121 |
SINOPEG manufactureshigh-purity methoxy-PEG-OH characterizedby absence of contaminating impurities and narrow molecular weight distributions. These highly pure methoxy-PEG-OH have so far been used for various commerical PEGylated drugs, such as PEG-Interferon and PEG-GCSF.
Ourmethoxy-PEG-OHhas the davantage of extremely low diol contents relative to those of competitors' products. Our methoxy-PEG-OH contains remarkably low levels of diol as impurities, besides providing a narrower distribution of molecular weights in comparison with our competitors' products. Employment of our methoxy-PEG-OH as the starting materials yields higher purity and higher activity of Actives PEGs. We manufacture highly pure methoxy-PEGs with pure methoxy-PEGs with molecular weights form 5KDa to 80KDa.
Our products are industrially recognized, industry leading benchmark products for key performance attributes: high LOT-to-LOT consistency, accurate molecular weight control, impurity profile (low impurities), strong analytical development work for each product to support drug dossier preparation.
SINOPEGis serving pharmaceutical and medical device companies around the globe, with product presence in various pharmaceutical/device development pipeline (pre-clinical, clinical, and post authorization large scale supply). Our facility is ISO9001 and ISO13485 certified, and is operating according to ICH Q7A guidelines to produce products for pharmaceutical companies.
Please contact us atsales@sinopeg.com for PEG derivatives. Our online catalog or inventory may not listed or have all molecular weights and functional groups, which may be available by custom synthesis. Please contact us atsales@sinopeg.com for quotation and availability.
License is required from license holder.
Reference:
1. Li Y, Lin J, Wang P, et al. Tumor Microenvironment Cascade-Responsive Nanodrug with Self-Targeting Activation and ROS Regeneration for Synergistic Oxidation-Chemotherapy. Nanomicro Lett. 2020;12(1):182. Published 2020 Sep 14. doi:10.1007/s40820-020-00492-4
2. Li Y, Lin J, Wang P, et al. Tumor Microenvironment Responsive Shape-Reversal Self-Targeting Virus-Inspired Nanodrug for Imaging-Guided Near-Infrared-II Photothermal Chemotherapy. ACS Nano. 2019;13(11):12912-12928. doi:10.1021/acsnano.9b05425
3. Sun F, Bu Y, Chen Y, Yang F, Yu J, Wu D. An Injectable and Instant Self-Healing Medical Adhesive for Wound Sealing. ACS Appl Mater Interfaces. 2020;12(8):9132-9140. doi:10.1021/acsami.0c01022
